Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 903258, 12 pages
http://dx.doi.org/10.1155/2014/903258
Research Article

Ananas comosus L. Leaf Phenols and p-Coumaric Acid Regulate Liver Fat Metabolism by Upregulating CPT-1 Expression

1Division of Life Science & Health, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China
2Zhu Jiang Hospital, Southern Medical University, Guangzhou 510282, China
3Protein Science Laboratory of the Ministry of Education, Laboratory of Pharmaceutical Science, School of Life Science, School of Medicine, Tsinghua University, Beijing 100084, China

Received 15 May 2014; Revised 11 July 2014; Accepted 21 July 2014; Published 12 August 2014

Academic Editor: Cheorl-Ho Kim

Copyright © 2014 Weidong Xie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Li, J. Xue, P. Chen, L. Chen, S. Yan, and L. Liu, “Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies,” Journal of Gastroenterology and Hepatology, vol. 29, pp. 42–51, 2014. View at Google Scholar
  2. D. A. Lawlor, M. Callaway, C. Macdonald-Wallis et al., “Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents,” Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 3, pp. E410–E417, 2014. View at Publisher · View at Google Scholar
  3. A. Nakamura and Y. Terauchi, “Lessons from mouse models of high-fat diet-induced NAFLD,” International Journal of Molecular Sciences, vol. 14, pp. 21240–21257, 2013. View at Google Scholar
  4. A. Kotronen, H. Yki-Järvinen, S. Männistö et al., “Non-alcoholic and alcoholic fatty liver disease–two diseases of affluence associated with the metabolic syndrome and type 2 Diabetes: the FIN-D2D survey,” BMC Public Health, vol. 10, article 237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Nakajima, “Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty Liver disease,” International Journal of Hepatology, vol. 2012, Article ID 950693, 13 pages, 2012. View at Publisher · View at Google Scholar
  6. A. Zambon and K. Cusi, “The role of fenofibrate in clinical practice,” Diabetes and Vascular Disease Research, vol. 4, no. 3, pp. S15–S20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Fernández-Miranda, M. Pérez-Carreras, F. Colina, G. López-Alonso, C. Vargas, and J. A. Solís-Herruzo, “A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease,” Digestive and Liver Disease, vol. 40, no. 3, pp. 200–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Eslami, S. Merat, R. Malekzadeh, S. Nasseri-Moghaddam, and H. Aramin, “Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis,” Cochrane Database Systematic Reviews, vol. 12, Article ID CD008623, 2013. View at Google Scholar
  9. L. L. Song, “Administrant department of national Chinese traditional medicine,” in Chinese Herbs, vol. 8, pp. 296–297, Shanghai, China, 1999, (Chinese). View at Google Scholar
  10. W. Xie, D. Xing, H. Sun, W. Wang, Y. Ding, and L. Du, “The effects of Ananas comosus L. leaves on diabetic-dyslipidemic rats induced by alloxan and a high-fat/high-cholesterol diet,” The American Journal of Chinese Medicine, vol. 33, no. 1, pp. 95–105, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Xie, W. Wang, H. Su, D. Xing, G. Cai, and L. Du, “Hypolipidemic mechanisms of Ananas comosus L. leaves in mice: different from fibrates but similar to statins,” Journal of Pharmacological Sciences, vol. 103, no. 3, pp. 267–274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. V. A. Zammit, “Carnitine palmitoyltransferase 1: central to cell function,” IUBMB Life, vol. 60, no. 5, pp. 347–354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. C. P. Aires, L. IJlst, F. Stet et al., “Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis,” Biochemical Pharmacology, vol. 79, no. 5, pp. 792–799, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Derdak, K. A. Villegas, R. Harb, A. M. Wu, A. Sousa, and J. R. Wands, “Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease,” Journal of Hepatology, vol. 58, no. 4, pp. 785–791, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Tsuruta, K. Nagao, S. Kai et al., “Polyphenolic extract of lotus root (edible rhizome of Nelumbo nucifera) alleviates hepatic steatosis in obese diabetic db/db mice,” Lipids in Health and Disease, vol. 10, article 202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. W.D. Xie, H. Wang, J. F. Zhang, H. F. Kung, Y. N. Zhao, and Y. Zhang, “Proteomic profile of visceral adipose tissues between low-fat diet-fed obesity-resistant and obesity-prone C57BL/6 mice,” Molecular Medicine Reports, vol. 3, no. 6, pp. 1047–1052, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Wang, Y. Ding, D. Xing, J. Wang, and L. Du, “Studies on phenolic constituents from leaves of pineapple (Ananas comosus),” Zhongguo Zhongyao Zazhi, vol. 31, no. 15, pp. 1242–1244, 2006. View at Google Scholar · View at Scopus
  18. Z. Meng, W. Wang, D. Xing, F. Lei, J. Lan, and L. Du, “Pharmacokinetic study of p-coumaric acid in mouse after oral administration of extract of Ananas comosus L. leaves,” Biomedical Chromatography, vol. 20, no. 9, pp. 951–955, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Xie, D. Gu, J. Li, K. Cui, and Y. Zhang, “Effects and action mechanisms of berberine and rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice,” PLoS ONE, vol. 6, no. 9, Article ID e24520, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Iossa, L. Lionetti, M. P. Mollica, R. Crescenzo, A. Barletta, and G. Liverini, “Effect of long-term high-fat feeding on energy balance and liver oxidative activity in rats,” British Journal of Nutrition, vol. 84, no. 3, pp. 377–385, 2000. View at Google Scholar · View at Scopus
  21. W. Xie, H. Wang, J. Zhang et al., “Enhanced peroxisomal β-oxidation metabolism in visceral adipose tissues of high-fat diet-fed obesity-resistant C57BL/6 mice,” Experimental and Therapeutic Medicine, vol. 2, no. 2, pp. 309–315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Zhang, J. Yang, Y. Guo et al., “Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis,” Hepatology, vol. 51, no. 4, pp. 1190–1199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Guo, R. A. Jolly, B. W. Halstead et al., “Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed Using rodent and canine hepatocytes,” Toxicological Sciences, vol. 96, no. 2, pp. 294–309, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. R. Bruce, C. Brolin, N. Turner et al., “Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 292, no. 4, pp. E1231–E1237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Schreurs, F. Kuipers, and F. R. van der Leij, “Regulatory enzymes of mitochondrial β-oxidation as targets for treatment of the metabolic syndrome,” Obesity Reviews, vol. 11, no. 5, pp. 380–388, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. R. A. K. Srivastava, S. L. Pinkosky, S. Filippov, J. C. Hanselman, C. T. Cramer, and R. S. Newton, “AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases,” Journal of Lipid Research, vol. 53, no. 12, pp. 2490–2514, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Fedorenko, P. V. Lishko, and Y. Kirichok, “Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria,” Cell, vol. 151, no. 2, pp. 400–413, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Rakhshandehroo, B. Knoch, M. Müller, and S. Kersten, “Peroxisome proliferator-activated receptor alpha target genes,” PPAR Research, vol. 2010, Article ID 612089, 20 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. E. M. Morris, M. R. Jackman, G. M. Meers et al., “Reduced hepatic mitochondrial respiration following acute high-fat diet is prevented by PGC-1α overexpression,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 305, pp. G868–G880, 2013. View at Google Scholar
  30. M. Miyazaki, I. Nakagawa, S. Koga, Y. Kasahara, and M. P. Patricelli, “Proteomics analysis of cardiac muscle from rats with peroxisomal proliferator-activated receptor a (PPARalpha) stimulation,” Journal of Toxicological Sciences, vol. 35, no. 1, pp. 131–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Song, R. R. Attia, S. Connaughton et al., “Peroxisome proliferator activated receptor α (PPARα) and PPAR gamma coactivator (PGC-1α) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements,” Molecular and Cellular Endocrinology, vol. 325, no. 1-2, pp. 54–63, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. F. R. van der Leij, V. W. Bloks, A. Grefhorst et al., “Gene expression profiling in livers of mice after acute inhibition of β-oxidation,” Genomics, vol. 90, no. 6, pp. 680–689, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. H. Koo, “Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis,” Clinical Molecular Hepatology, vol. 19, pp. 210–215, 2013. View at Publisher · View at Google Scholar
  34. Y. Sumida, E. Niki, Y. Naito, and T. Yoshikawa, “Involvement of free radicals and stress,” Free Radical Research, vol. 47, pp. 869–880, 2013. View at Google Scholar